NEUE: Rega marang dodolan NeueHealth Inc.

Management restructuring at NeueHealth, Inc. (NEUE) aimed at stabilizing margins is creating the groundwork for an asset revaluation, and the current price-to-sales ratio on the GURU.Markets terminal confirms this, with the current mark equal to 0.10. Revenues are based on Medicare services, while the implementation of digital platforms connecting physicians with patients increases billing transparency and overall treatment efficiency.

NEUE: Multiplikator P/S NeueHealth, Inc. 21.02.2024 - 18.10.2025

Rincian metrik lan analitis perusahaan NeueHealth, Inc. (NEUE)

- nilai saham lan prakiraan konsensus rega:

Rega saham neuehealth.com|NEUE - Prakiraan konsensus analis

- informasi kapitalisasi pasar:

Nilai pasar NeueHealth Corp|NEUE - Nilai Perusahaan

- data nilai buku modal saham:

Nilai Akuntansi Saham NeueHealth|NEUE - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku neuehealth.com|NEUE - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Total Utang marang Modal NeueHealth, Inc.|NEUE - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas neuehealth.com|NEUE - Gunggung utang perusahaan|Utang marang modal buku NeueHealth Corp|NEUE - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan NeueHealth|Rasio jangkoan perantara neuehealth.com

- informasi bathi lan kelipatan valuasi:

NEUE - Bathi resik|Prakiraan bathi perusahaan NeueHealth, Inc.|NEUE - Rasio rega marang bathi|Rasio rega marang bathi mangsa ngarep neuehealth.com|NEUE - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NeueHealth Corp|NEUE - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan NeueHealth|NEUE - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan neuehealth.com|NEUE - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep NeueHealth, Inc.

- rincian pendapatan lan dodolan emiten:

NEUE - Dodolan perusahaan|Prakiraan volume dodolan neuehealth.com|NEUE - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep NeueHealth Corp

Ringkesan analitik perusahaan:NeueHealth Inc.

The scale of NeueHealth, Inc. (NEUE) operations and market expectations are reflected in the fluctuations of the P/S multiple. This ratio compares current market capitalization to annual revenue, determining the value of each dollar of sales. For the investor, this serves as a measure of asset overvaluation, directly dependent on the efficiency of payment management and Medicare Advantage client retention. Long-term consensus is formed through an analysis of the historical extremes of this ratio.

Perusahaan pesaing

Multiplikator P/S unitedhealthgroup.com (UNH)|Multiplikator P/S CI (Cigna)|Aflac Inc. (AFL) - Rega marang dodolan|Humana Health - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan CNC (Centene Health)|MOH: Multiplikator P/S|Rega marang dodolan maximus.com (MMS)|OSCR (Oscar Health) - Multiplikator P/S|Multiplikator P/S Clover Health Investments, Corp.|Rasio rega marang pendapatan Claritev Inc. (CTEV)|Rasio rega marang pendapatan YB (Yuanbao Corp)|Health In Tech - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan EHTH (eHealth Inc.)|GoHealth - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan RELI (Reliance Global Group Inc)|LIFW (LifeWallet) - Kapitalisasi marang pendapatan|MultiPlan Inc. - Rasio kapitalisasi pasar marang pendapatan